The significance of avian influenza virus mouse-adaptation and its application in characterizing the efficacy of new vaccines and therapeutic agents

다국어 초록 (Multilingual Abstract)

Due to the increased frequency of interspecies transmission of avian influenza viruses, studies designed to identify the molecular determinants that could lead to an expansion of the host range have been increased. A variety of mouse-based mammalian-adaptation studies of avian influenza viruses have provided insight into the genetic alterations of various avian influenza subtypes that may contribute to the generation of a pandemic virus. To date, the studies have focused on avian influenza subtypes H5, H6, H7, H9, and H10 which have recently caused human infection. Although mice cannot fully reflect the course of human infection with avian influenza, these mouse studies can be a useful method for investigating potential mammalian adaptive markers against newly emerging avian influenza viruses. In addition, due to the lack of appropriate vaccines against the diverse emerging influenza viruses, the generation of mouse-adapted lethal variants could contribute to the development of effective vaccines or therapeutic agents. Within this review, we will summarize studies that have demonstrated adaptations of avian influenza viruses that result in an altered pathogenicity in mice which may suggest the potential application of mouse-lethal strains in the development of influenza vaccines and/or therapeutics in preclinical studies.

참고문헌 (Reference)

1 World Health Organization., "World now at the start of 2009 influenza pandemic" World Health Organization

2 Liu Q, "Virulence determinants in the PB2 gene of a mouse-adapted H9N2 virus" 89 : 877-882, 2015

3 Kim SM, "Vaccine efficacy of inactivated, chimeric hemagglutinin H9/H5N2 avian influenza virus and its suitability for the marker vaccine strategy" 91 : e01693-e01616, 2017

4 Gabriel G, "The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host" 102 : 18590-18595, 2005

5 Song MS, "The polymerase acidic protein gene of influenza a virus contributes to pathogenicity in a mouse model" 83 : 12325-12335, 2009

6 Leneva IA, "The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/ 156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses" 48 : 101-115, 2000

7 Lowen AC, "The guinea pig as a transmission model for human influenza viruses" 103 : 9988-9992, 2006

8 Belser JA, "The ferret as a model organism to study influenza A virus infection" 4 : 575-579, 2011

9 Long JS, "The effect of the PB2 mutation 627K on highly pathogenic H5N1 avian influenza virus is dependent on the virus lineage" 87 : 9983-9996, 2013

10 Dalby AR, "The European and Japanese outbreaks of H5N8 derive from a single source population providing evidence for the dispersal along the long distance bird migratory flyways" 3 : e934-, 2015

11 Shim BS, "Sublingual immunization with M2-based vaccine induces broad protective immunity against influenza" 6 : e27953-, 2011

12 Tzarum N, "Structure and receptor binding of the hemagglutinin from a human H6N1 influenza virus" 17 : 369-376, 2015

13 Li J, "Single mutation at the amino acid position 627 of PB2 that leads to increased virulence of an H5N1 avian influenza virus during adaptation in mice can be compensated by multiple mutations at other sites of PB2" 144 : 123-129, 2009

14 Centers for Disease Control and Prevention (CDC)., "Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine" 58 : 521-524, 2009

15 Wu A, "Sequential reassortments underlie diverse influenza H7N9 genotypes in China" 14 : 446-452, 2013

16 Mase M, "Recent H5N1 avian influenza A virus increases rapidly in virulence to mice after a single passage in mice" 87 (87): 3655-3659, 2006

17 de Vries E, "Rapid emergence of highly pathogenic avian influenza subtypes from a subtype H5N1 hemagglutinin variant" 21 : 842-846, 2015

18 de Jong RM, "Rapid emergence of a virulent PB2 E627K variant during adaptation of highly pathogenic avian influenza H7N7 virus to mice" 10 : 276-, 2013

19 Sang X, "Rapid emergence of a PB2-E627K substitution confers a virulent phenotype to an H9N2 avian influenza virus during adoption in mice" 160 : 1267-1277, 2015

20 Choi WS, "Rapid acquisition of polymorphic virulence markers during adaptation of highly pathogenic avian influenza H5N8 virus in the mouse" 7 : 40667-, 2017

21 Qiu M, "Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice" 343 : 1124-1131, 2006

22 Kim EH, "Prokaryote-expressed M2e protein improves H9N2 influenza vaccine efficacy and protection against lethal influenza A virus in mice" 10 : 104-, 2013

23 Smirnov YA, "Prevention and treatment of bronchopneumonia in mice caused by mouse-adapted variant of avian H5N2 influenza A virus using monoclonal antibody against conserved epitope in the HA stem region" 145 : 1733-1741, 2000

24 Abdelwhab EM, "Prevalence and control of H7 avian influenza viruses in birds and humans" 142 : 896-920, 2014

25 Liu D, "Poultry carrying H9N2 act as incubators for novel human avian influenza viruses" 383 : 869-, 2014

26 Zanin M, "Potential for low-pathogenic avian H7 influenza A viruses to replicate and cause disease in a mammalian model" 91 : e01934-e01916, 2017

27 Gambaryan AS, "Polymer-bound 6’ sialyl-N-acetyllactosamine protects mice infected by influenza virus" 68 : 116-123, 2005

28 Brown EG, "Pattern of mutation in the genome of influenza A virus on adaptation to increased virulence in the mouse lung : identification of functional themes" 98 : 6883-6888, 2001

29 Pulit-Penaloza JA, "Pathogenesis and transmission of novel highly pathogenic avian influenza H5N2 and H5N8 viruses in ferrets and mice" 89 : 10286-10293, 2015

30 Kim YI, "Pathobiological features of a novel, highly pathogenic avian influenza A(H5N8) virus" 3 : e75-, 2014

31 Berhane Y, "Pathobiological characterization of a novel reassortant highly pathogenic H5N1 virus isolated in British Columbia, Canada, 2015" 6 : 23380-, 2016

32 Cheng K, "PB2-E627K and PA-T97I substitutions enhance polymerase activity and confer a virulent phenotype to an H6N1 avian influenza virus in mice" 468-470 : 207-213, 2014

33 Smith GJ, "Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic" 459 : 1122-1125, 2009

34 Shi W, "Origin and molecular characterization of the human-infecting H6N1 influenza virus in Taiwan" 4 : 846-853, 2013

35 Yuan J, "Origin and molecular characteristics of a novel 2013 avian influenza A(H6N1) virus causing human infection in Taiwan" 57 : 1367-1368, 2013

36 Gu M, "Novel reassortant highly pathogenic avian influenza (H5N5) viruses in domestic ducks" 17 : 1060-1063, 2011

37 Wu H, "Novel reassortant H10N7 avian influenza viruses isolated from chickens in Eastern China" 65 : 58-61, 2015

38 Lee YT, "New vaccines against influenza virus" 3 : 12-28, 2014

39 Wu H, "Multiple amino acid substitutions involved in the adaptation of avian-origin influenza A (H10N7) virus in mice" 161 : 977-980, 2016

40 Yu Z, "Multiple amino acid substitutions involved in the adaptation of H6N1 avian influenza virus in mice" 174 : 316-321, 2014

41 Zhang Z, "Multiple amino acid substitutions involved in enhanced pathogenicity of LPAI H9N2 in mice" 11 : 1790-1797, 2011

42 Wu R, "Multiple amino acid substitutions are involved in the adaptation of H9N2 avian influenza virus to mice" 138 : 85-91, 2009

43 Park KS, "Mucosal immunity induced by adenovirus-based H5N1 HPAI vaccine confers protection against a lethal H5N2 avian influenza virus challenge" 395 : 182-189, 2009

44 Wang J, "Mouse-adapted H9N2 influenza A virus PB2 protein M147L and E627K mutations are critical for high virulence" 7 : e40752-, 2012

45 Han P, Hu Y, Sun W, "Mouse lung-adapted mutation of E190G in hemagglutinin from H5N1 influenza virus contributes to attenuation in mice" 87 : 1816-1822, 2015

46 Kamal RP, "Molecular determinants of influenza virus pathogenesis in mice" 385 : 243-274, 2014

47 박국진, "Molecular characterization of mammalian-adapted Korean-type avian H9N2 virus and evaluation of its virulence in mice" 한국미생물학회 53 (53): 570-577, 2015

48 Guan Y, "Molecular characterization of H9N2 influenza viruses: were they the donors of the “internal” genes of H5N1 viruses in Hong Kong?" 96 : 9363-9367, 1999

49 Hatta M, "Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses" 293 : 1840-1842, 2001

50 Min JY, "Mammalian adaptation in the PB2 gene of avian H5N1 influenza virus" 87 : 10884-10888, 2013

51 Govorkova EA, "Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004" 79 : 2191-2198, 2005

52 Wu H, "Isolation and characterization of a novel H10N2 avian influenza virus from a domestic duck in Eastern China" 29 : 1-5, 2015

53 Saito T, "Intracontinental and intercontinental dissemination of Asian H5 highly pathogenic avian influenza virus (clade 2.3.4.4) in the winter of 2014-2015" 25 : 388-405, 2015

54 Sidwell RW, "Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor" 37 : 107-120, 1998

55 Kilbourne ED., "Influenza pandemics of the 20th century" 12 : 9-14, 2006

56 Francis T, "Immunological studies with the virus of influenza" 62 : 505-516, 1935

57 Taft AS, "Identification of mammalian-adapting mutations in the polymerase complex of an avian H5N1 influenza virus" 6 : 7491-, 2015

58 Claas EC, "Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus" 351 : 472-477, 1998

59 Peiris M, "Human infection with influenza H9N2" 354 : 916-917, 1999

60 Yang ZF, "Human infection with a novel avian influenza A(H5N6) virus" 373 : 487-489, 2015

61 Capua I, "Highly pathogenic avian influenza (H7N1) in ostriches (Struthio camelus)" 29 : 643-646, 2000

62 Lowen AC, "High temperature (30 degrees C) blocks aerosol but not contact transmission of influenza virus" 82 : 5650-5652, 2008

63 Chen H, "High pathogenicity of in fluenza A (H10N8) virus in mice" 93 : 1360-1363, 2015

64 Wang G, "H6 influenza viruses pose a potential threat to human health" 88 : 3953-3964, 2014

65 Perrone LA, "H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice" 4 : e1000115-, 2008

66 Hatta M, "Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice" 3 : 1374-1379, 2007

67 Kim HR, "Genetic relatedness of H6 subtype avian influenza viruses isolated from wild birds and domestic ducks in Korea and their pathogenicity in animals" 91 (91): 208-219, 2010

68 Liu M, "Genetic diversity of avian influenza A (H10N8) virus in live poultry markets and its association with human infections in China" 5 : 7632-, 2015

69 Kim YI, "Genetic diversity and pathogenic potential of low pathogenic H7 avian influenza viruses isolated from wild migratory birds in Korea" 45 : 268-284, 2016

70 Yang L, "Genesis and dissemination of highly pathogenic H5N6 avian influenza viruses" 91 : e02199-e02116, 2017

71 Webster RG, "Evolution and ecology of influenza A viruses" 56 : 152-179, 1992

72 송민석, "Evaluation of the Efficacy of a Pre-pandemic H5N1 Vaccine (MG1109) in Mouse and Ferret Models" 한국미생물학회 50 (50): 478-488, 2012

73 Joseph T, "Evaluation of replication and pathogenicity of avian influenza a H7 subtype viruses in a mouse model" 81 : 10558-10566, 2007

74 Su S, "Epidemiology, evolution, and recent outbreaks of avian influenza virus in China" 89 : 8671-8676, 2015

75 Li Q, "Epidemiology of human infections with avian influenza A(H7N9) virus in China" 370 : 520-532, 2014

76 Nam JH, "Emergence of mammalian species-infectious and -pathogenic avian influenza H6N5 virus with no evidence of adaptation" 85 : 13271-13277, 2011

77 Takahashi K, "Efficacy of recombinant chimeric lectins, consisting of mannose binding lectin and L-ficolin, against influenza A viral infection in mouse model study" 178 : 495-501, 2013

78 D’Agostini C, "Efficacy of combination therapy with amantadine, thymosin alpha 1 and alpha/beta interferon in mice infected with influenza A virus" 18 : 95-102, 1996

79 Food Agriculture Organization., "Diseases Events (search criteria: disease list; H5N1 HPAI, H5N6 HPAI, H7N9 LPAI, H7N9 HPAI/animal affected; human)" Food Agriculture Organization

80 Lipatov AS, "Differences between original strains and their mouse-adapted variants of human (H1) and avian (H2) influenza A viruses in the reaction with cross-neutralizing monoclonal antibody recognizing conformational epitope" 40 : 227-230, 1996

81 Pasick J, "Diagnostic test results and pathology associated with the 2007 Canadian H7N3 highly pathogenic avian influenza outbreak" 54 (54): 213-219, 2010

82 Choi EH, "Development of a dual-protective live attenuated vaccine against H5N1 and H9N2 avian influenza viruses by modifying the NS1 gene" 160 : 1729-1740, 2015

83 Mei K, "Deep sequencing reveals the viral adaptation process of environment-derived H10N8 in mice" 37 : 8-13, 2016

84 World Health Oranization., "Cumulative number of confirmed human cases of avian influenza A(H5N1) reported to WHO" World Health Organization

85 Lee YJ, "Continuing evolution of H9 influenza viruses in Korean poultry" 359 : 313-323, 2007

86 Park KS, "Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e" 29 : 5481-5487, 2011

87 Govorkova EA, "Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses" 45 : 2723-2732, 2001

88 Jang YH, "Cold-adapted pandemic 2009 H1N1 influenza virus live vaccine elicits cross-reactive immune responses against seasonal and H5 influenza A viruses" 86 : 5953-5958, 2012

89 Chen H, "Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: a descriptive study" 383 : 714-721, 2014

90 Hinshaw VS, "Circulation of influenza viruses and paramyxoviruses in waterfowl originating from two different areas of North America" 63 : 711-719, 1985

91 Guo YJ, "Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia" 267 : 279-288, 2000

92 Zhang M, "Characterization of the pathogenesis of H10N3, H10N7, and H10N8 subtype avian influenza viruses circulating in ducks" 6 : 34489-, 2016

93 Yao Y, "Characterization of low-pathogenic H6N6 avian influenza viruses in central China" 158 : 367-377, 2013

94 Smirnov YA, "Characterization of adaptation of an avian influenza A (H5N2) virus to a mammalian host" 44 : 1-8, 2000

95 Zhang H, "Characterization of H9N2 influenza viruses isolated from Dongting Lake wetland in 2007" 156 : 95-105, 2011

96 Gitelman AK, "Changes in the antigenic specificity of influenza hemagglutinin in the course of adaptation to mice" 134 : 230-232, 1984

97 World Health Organization., "Avian influenza weekly update number 579" World Health Organization

98 Malik Peiris JS., "Avian influenza viruses in humans" 28 (28): 161-173, 2009

99 Choi YK, "Avian influenza viruses in Korean live poultry markets and their pathogenic potential" 332 : 529-537, 2005

100 Homme PJ, "Avian influenza virus infections. I. Characteristics of influenza A-turkey-Wisconsin-1966 virus" 14 : 66-74, 1970

101 van den Berg T, "Avian influenza outbreak management: action at time of confirmation, depopulation and disposal methods; the ‘Belgian experience’ during the H7N7 highly pathogenic avian influenza epidemic in 2003" 55 : 54-64, 2008

102 Gillim-Ross L, "Avian influenza h6 viruses productively infect and cause illness in mice and ferrets" 82 : 10854-10863, 2008

103 Peng X, "Amino acid substitutions occurring during adaptation of an emergent H5N6 avian influenza virus to mammals" 161 : 1665-1670, 2016

104 Wu H, "Amino acid substitutions involved in the adaptation of a novel highly pathogenic H5N2 avian influenza virus in mice" 13 : 159-, 2016

105 Li Q, "Adaptive mutations in PB2 gene contribute to the high virulence of a natural reassortant H5N2 avian influenza virus in mice" 210 : 255-263, 2015

106 Chen Q, "Adaptive amino acid substitutions enhance the virulence of an H7N7 avian influenza virus isolated from wild waterfowl in mice" 177 : 18-24, 2015

107 Yu Z, "Adaptive amino acid substitutions enhance the virulence of a reassortant H7N1 avian influenza virus isolated from wild waterfowl in mice" 476 : 233-239, 2015

108 Zhao Y, "Adaptive amino acid substitutions enhance the virulence of a novel human H7N9 influenza virus in mice" 187 : 8-14, 2016

109 Shinya K, "Adaptation of an H7N7 equine influenza A virus in mice" 88 (88): 547-553, 2007

110 Li Q, "Adaptation of a natural reassortant H5N2 avian influenza virus in mice" 172 : 568-574, 2014

111 Khan SU, "A systematic review and meta-analysis of the seroprevalence of influenza A(H9N2) infection among humans" 212 : 562-569, 2015

112 Subbarao EK, "A single amino acid in the PB2 gene of influenza A virus is a determinant of host range" 67 : 1761-1764, 1993

113 Tian J, "A single E627K mutation in the PB2 protein of H9N2 avian influenza virus increases virulence by inducing higher glucocorticoids (GCs) level" 7 : e38233-, 2012

114 Liu Q, "A nonpathogenic duck-origin H9N2 influenza A virus adapts to high pathogenicity in mice" 159 : 2243-2252, 2014

115 Lu X, "A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans" 73 : 5903-5911, 1999

116 Tan L, "A combination of HA and PA mutations enhances virulence in a mouse-adapted H6N6 influenza A virus" 88 : 14116-14125, 2014